This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

The Art and Science of Switching Antipsychotic Medications, Part 2

Peter J. Weiden, MD; Alexander L. Miller, MD; Tim J. Lambert, BSc, MBBS, FRANZCP, PhD; and Peter F. Buckley, MD (Chair)

Published: January 15, 2007

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

In the presentation "Switching and Metabolic Syndrome,"Weiden summarizes reasons to switch antipsychotics, highlighting weight gainand other metabolic adverse events as recent treatment targets. In "TexasMedication Algorithm Project (TMAP)," Miller reviews the TMAP study design,discusses results related to the algorithm versus treatment as usual, andconcludes with the implications of the study. Lambert’s presentation, "Dosingand Titration Strategies to Optimize Patient Outcome When SwitchingAntipsychotic Therapy," reviews the decision-making process when switchingpatients’ medication, addresses dosing and titration strategies to effectivelytransition between medications, and examines other factors to consider whenswitching pharmacotherapy.

See the entire activity.‘ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: